研究概要
我们开发了一种更安全、更高效的临床级嗅干细胞生产工艺。通过该方案,人OE-MSC不久将用于一项基于自体移植治疗被忽视损伤的指神经的I期临床。然而,仍需进一步研究以揭示其潜在作用机制。
研究思路结论见上方概要
背景
嗅觉外胚层间充质干细胞(OE-MSC)是来源于鼻黏膜固有层的间充质干细胞。它们表现出神经发生和免疫调节特性,并已被证明可在脊髓创伤、听力损失、帕金森病、遗忘症和周围神经损伤的动物模型中诱导恢复。作为迈向临床实践的一步,我们试图(i)设计一种符合人类健康机构要求的培养方案,并(ii)评估干细胞对神经元分化的功效。
方法
来自三名供体的鼻嗅黏膜活检样本被用于设计并验证纯化干细胞的良好生产流程。所有流程和操作均由马赛公立医院(AP-HM)细胞治疗实验室的专业人员按照无菌操作规范执行。场所、材料和空气始终保持清洁,以避免交叉污染、事故甚至死亡事件。纯化后的干细胞培养24或48小时,收集条件培养基后加入神经母细胞瘤细胞系Neuro2a的培养液中。
结果
与基于外植体培养的方案相比,酶消化能更快速地提供更高的细胞数量,且更不易受到污染。使用血小板裂解物替代胎牛血清可有效促进更高的细胞增殖(CFU-F祖细胞百分比为15.5%),血小板裂解物的最佳百分比为10%。培养的OE-MSCs未显示染色体重排,并且如预期那样表达间充质干细胞的常见表型标志物。当加入标准培养基中时,纯化OE-MSCs的条件培养基可促进Neuro2a神经母细胞瘤细胞的细胞分化。
展开英文摘要原文
BACKGROUND: Olfactory ecto-mesenchymal stem cells (OE-MSC) are mesenchymal stem cells derived from the lamina propria of the nasal mucosa. They display neurogenic and immunomodulatory properties and were shown to induce recovery in animal models of spinal cord trauma, hearing loss, Parkinsons's disease, amnesia, and peripheral nerve injury. As a step toward clinical practice, we sought to (i) devise a culture protocol that meets the requirements set by human health agencies and (ii) assess the efficacy of stem cells on neuron differentiation.
METHODS: Nasal olfactory mucosa biopsies from three donors were used to design and validate the good manufacturing process for purifying stem cells. All processes and procedures were performed by expert staff from the cell therapy laboratory of the public hospital of Marseille (AP-HM), according to aseptic handling manipulations. Premises, materials and air were kept clean at all times to avoid cross-contamination, accidents, or even fatalities. Purified stem cells were cultivated for 24 or 48 h and conditioned media were collected before being added to the culture medium of the neuroblastoma cell line Neuro2a.
RESULTS: Compared to the explant culture-based protocol, enzymatic digestion provides higher cell numbers more rapidly and is less prone to contamination. The use of platelet lysate in place of fetal calf serum is effective in promoting higher cell proliferation (the percentage of CFU-F progenitors is 15.5%), with the optimal percentage of platelet lysate being 10%. Cultured OE-MSCs do not show chromosomal rearrangement and, as expected, express the usual phenotypic markers of mesenchymal stem cells. When incorporated in standard culture medium, the conditioned medium of purified OE-MSCs promotes cell differentiation of Neuro2a neuroblastoma cells.
CONCLUSION: We developed a safer and more efficient manufacturing process for clinical grade olfactory stem cells. With this protocol, human OE-MSCs will soon be used in a Phase I clinical based on their autologous transplantation in digital nerves with a neglected injury. However, further studies are required to unveil the underlying mechanisms of action.
论文信息
- 作者
- Jaloux C、Bonnet M、Vogtensperger M、Witters M、Veran J、Giraudo L、Sabatier F、Michel J
- 单位
- CNRS, INP, UMR 7051, Institut de Neuropathophysiologie, Equipe Nasal Olfactory Stemness and Epigenesis (NOSE), Aix Marseille University, Marseille, France.France
- 期刊
- Frontiers in neuroscience2022